Charmacy Pharmaceutical Co., Ltd.
HKSE: 2289.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Chuanglong Yao
- Employees
- 847
- Headquarters
- Shantou, China
- IPO year
- 2015
- Market cap
- HK$628.6M
- Website
- https://www.chmyy.com
Loading 2289…
Loading profile data…Frequently asked questions about 2289
What does Charmacy Pharmaceutical Co., Ltd. (2289.HK) do?
Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platfo...
Where does 2289.HK trade?
Charmacy Pharmaceutical Co., Ltd. (2289.HK) trades on the Hong Kong Stock Exchange.
What sector is 2289.HK in?
Charmacy Pharmaceutical Co., Ltd. (2289.HK) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Charmacy Pharmaceutical Co., Ltd.?
Chuanglong Yao is the chief executive officer of Charmacy Pharmaceutical Co., Ltd. (2289.HK).
Where is Charmacy Pharmaceutical Co., Ltd. headquartered?
Charmacy Pharmaceutical Co., Ltd. is headquartered in China.
Does 2289.HK pay a dividend?
Yes — Charmacy Pharmaceutical Co., Ltd. (2289.HK) paid a trailing twelve-month dividend of HKD 0.49 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2289.HK go public?
Charmacy Pharmaceutical Co., Ltd. (2289.HK) completed its initial public offering in 2015.